NCT03740529 2026-01-27A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHLEli Lilly and CompanyPhase 1/2 Completed803 enrolled 2 FDA
NCT06220032 2026-01-05HO170DLBCLStichting Hemato-Oncologie voor Volwassenen NederlandPhase 3 Recruiting324 enrolled